Shutterstock
As the pharma industry evolves and advanced therapeutics such as gene therapies and cell-based products gain momentum in the market, the demand for rapid timelines from development to commercialisation is rising. Development and manufacturing speed is critical for drug manufacturers to expedite medicines that have the potential to change patients’ lives. In addition, they need to demonstrate a return on investment to investors to keep developing and driving products forward.